| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |